This Science News Wire page contains a press release issued by an organization and is provided to you "as is" with little or no review from Science X staff.

Certain factors may predict lung cancer patients' response to chemotherapy

January 10th, 2018

In a retrospective analysis of 73 lung squamous cell carcinoma patients treated with the chemotherapy regimen of gemcitabine plus cisplatin, higher body mass index and younger age were linked with longer progression-free survival, the length of time that a patient lives with cancer but it does not get worse.

Patients with better response to treatment and higher body mass index had longer overall survival in the Thoracic Cancer analysis.

"Patients' clinical pathological characteristics may be used to predict the therapeutic efficacy of chemotherapy and survival," the authors wrote.

More information:
Thoracic Cancer, DOI: 10.1111/1759-7714.12581

Provided by Wiley

Citation: Certain factors may predict lung cancer patients' response to chemotherapy (2018, January 10) retrieved 24 September 2025 from https://sciencex.com/wire-news/277014200/certain-factors-may-predict-lung-cancer-patients-response-to-che.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.